Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Singlera Genomics has demonstrated strong clinical results with its GutSeer® assay for non-invasive early detection of five major gastrointestinal cancers using a simple blood test. The GUIDE study showed robust performance in real-world multi-center settings. The company’s PanSeer® pan-cancer screening technology and ColonES® colorectal cancer test are also being commercialized globally through partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singlera Genomics.